Monitoring the movement of medicines from the manufacturer to the customers
The system of automated control of circulation of medicines, as well as their sale to privileged categories of citizens

The most important problems of the pharmaceutical market in Russia

The problem of turnover in the pharmaceutical market of counterfeit medicines has become a national disaster. Experts say that up to 40% of medicines in Russia are of poor quality. The shaft of fakes is the scourge of the domestic pharmaceutical market. Assessment of annual damage from the turnover of counterfeit finished medicines - 30 billion rubles.

The Russian authorities are paying special attention to this problem. The fight against fakes in the pharmaceutical market are law enforcement agencies, the Ministry of health and Roszdravnadzor.

Another unsolved problem of the pharmaceutical market is the lack of an effective mechanism for providing medicines to privileged categories of citizens and targeted compensation for their implementation.

Transparent procedure for obtaining preferential pharmaceuticals and targeted compensation for their implementation
Single database
Unified register containing data on the movement of pharmaceuticals from the manufacturer to the end user
Quality assurance
Countering the emergence of counterfeit medicines, dietary supplements and medical products in legal circulation
One system is solution of several problems!

The proposed system provides reliable control over the turnover of pharmaceuticals throughout the country, as well as creates a convenient for citizens and effective for the state mechanism for providing preferential medicines, implementing the functions of:

  • Deployment of infocommunication infrastructure necessary to account for the movement of pharmaceuticals throughout the supply chain;
  • Counteraction to entering into legal circulation of counterfeit pharmaceutical products;
  • Real-time movement control of pharmaceuticals from the manufacturer to the end user;
  • Automatic recording of signs of corpus delicti in case of counterfeit and abuse detection;
  • Control over the use of pharmaceutical products in hospitals, pharmacies;
The system is a platform for deploying management tools preferential policies, ensure the implementation of transparent procedures for the vacation of medicines for privileged categories of citizens and establish an effective mechanism of targeted compensation for the implemented preferential medicines.
Elements of the system of automated control over the circulation of medicines

  • RFID tags (integrated into the packaging materials of pharmaceuticals, are used to identify individual, ampole, group and pallet packages of medicines);
  • Arched RFID reader (installed in warehouses and industrial complexes, is used to account for the flow of products);
  • RFID-reader for cash and POS-terminals (integrated with cash and POS-equipment of retail outlets, is used for registration of drug dispensing operations, as well as for their identification);
  • Mobile RFID-reader (used for in-line identification of drug packages during the operations of acceptance, release and inventory in warehouse complexes);
  • Server SOFTWARE (used to collect, aggregate and analyze information from other components of the system, is a platform for the deployment of preferential policy management tools, business intelligence and rapid detection of illegal operations).

The effect of the system is a guarantee of the quality of medicines!

The introduction of automated control system of turnover of medicines will provide:

  • Сollection and analysis of reliable information on the movement of medicinal and narcotic products;
  • Elimination of the possibility of introduction of counterfeit goods into the existing supply chains of Pharmaceuticals, supplements and medical products;
  • Transparent mechanism of accounting of medicines for privileged categories of citizens;
  • The possibility of immediate response to changes in the epidemiological situation in the country;
  • Protection from unauthorized release of drug-containing pharmaceuticals;
  • Confidence of the end customer in the quality of purchased medicines, supplements and medical products;
  • Optimization of warehouse logistics costs for pharmaceutical companies due to the mechanism of rapid inventory.